Balyasny Asset Management’s Korsana Biosciences, Inc. Common Stock KRSA Stock Holding History

Balyasny Asset Management’s Portfolio KRSA Stock Details KRSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.08M	Buy	+45,359	New	+$147K	﹤0.01%	2169

Other funds holding KRSA

KCM

Kalehua Capital Management Dallas, Texas $174M AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Rangeley Capital New Canaan, Connecticut $109M AUM 97.13% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Balyasny Asset Management's KRSA Position: Q2 2026 in Review

Balyasny Asset Management opened a new position in Korsana Biosciences, Inc. Common Stock (KRSA) in Q2 2026: 45,359 shares worth $1.08M. The stake represents ﹤0.01% of the portfolio and ranks #2169 among its holdings.

21 funds tracked by Wall St. Rank hold KRSA as of Q2 2026.

Balyasny Asset Management held 45,359 shares of Korsana Biosciences, Inc. Common Stock worth $1.08M as of Q2 2026.
Korsana Biosciences, Inc. Common Stock was a new Balyasny Asset Management position in Q2 2026.
Korsana Biosciences, Inc. Common Stock made up ﹤0.01% of Balyasny Asset Management's portfolio in Q2 2026, its #2169 holding.
21 funds tracked by Wall St. Rank held Korsana Biosciences, Inc. Common Stock as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.